keratitis/мачнина

Врската е зачувана во таблата со исечоци

Изберете вид на сортирање

13 резултати

Interstitial Keratitis, Vertigo, and Vasculitis: Typical Cogan's Syndrome.

Само регистрираните корисници можат да преведуваат статии

Пријавете се / пријавете се

Cogan's syndrome (CS) is a chronic inflammatory disorder of unknown etiology that most commonly affects young adults. Clinical hallmarks are bilateral interstitial keratitis and vestibuloauditory dysfunction. Association between CS and systemic vasculitis as well as aortitis also exists. The

Rituximab ameliorated severe hearing loss in Cogan's syndrome: a case report.

Само регистрираните корисници можат да преведуваат статии

Пријавете се / пријавете се

BACKGROUND Rituximab is a monoclonal antibody inducing depletion of B lymphocytes and presently approved for the treatment of non-Hodgkin's lymphoma and rheumatoid arthritis. Here is the first report of the use of this drug in a case of Cogan's syndrome (CS). METHODS a 25-year-old Italian woman was

Exposure to liquid detergent capsules: a study undertaken by the UK National Poisons Information Service.

Само регистрираните корисници можат да преведуваат статии

Пријавете се / пријавете се

OBJECTIVE To ascertain the reported toxicity of liquid detergent capsules. METHODS Between 1 March 2008 and 30 April 2009 the UK National Poisons Information Service collected prospectively 647 telephone enquiries relating to liquid detergent capsules. RESULTS The majority of enquiries (96.1%)

Botulinum-A toxin in the treatment of craniocervical muscle spasms: short- and long-term, local and systemic effects.

Само регистрираните корисници можат да преведуваат статии

Пријавете се / пријавете се

Botulinum toxin has become the initial treatment of choice for the management of essential blepharospasm, hemifacial spasm and other craniocervical dystonias. Numerous studies have confirmed a 90% to 95% response rate. Although a number of common side effects have been reported, the occurrence and

Safety and efficacy of an 8-week regimen of grazoprevir plus ruzasvir plus uprifosbuvir compared with grazoprevir plus elbasvir plus uprifosbuvir in participants without cirrhosis infected with hepatitis C virus genotypes 1, 2, or 3 (C-CREST-1 and C-CREST-2, part A): two randomised, phase 2, open-label trials.

Само регистрираните корисници можат да преведуваат статии

Пријавете се / пријавете се

New hepatitis C virus (HCV) therapies with pan-genotypic efficacy are needed. The goals of part A of C-CREST-1 and C-CREST-2 were to compare the efficacies of two doses (300 mg or 450 mg once daily) of uprifosbuvir (MK-3682; NS5B inhibitor) in an 8-week regimen combined with grazoprevir (NS3/4A

Noncosmetic periocular therapeutic applications of botulinum toxin.

Само регистрираните корисници можат да преведуваат статии

Пријавете се / пријавете се

Botulinum toxin blocks acetylcholine release at the neuromuscular junction. The drug which was initially found to be useful in the treatment of strabismus has been extremely effective in the treatment of variety of conditions, both cosmetic and noncosmetic. Some of the noncosmetic uses of botulinum

Low-dose pulsed intravenous cyclophosphamide for severe ocular cicatricial pemphigoid in elderly patients.

Само регистрираните корисници можат да преведуваат статии

Пријавете се / пријавете се

OBJECTIVE Ocular cicatricial pemphigoid (OCP) is a relatively rare autoimmune disease affecting elderly patients and causing severe symptoms that may culminate in blindness. Treatment is based on immunosuppression, but optimal regimens have not been established. METHODS A prospective unmasked case

Granulomatosis with polyangiitis: seeing the diagnosis.

Само регистрираните корисници можат да преведуваат статии

Пријавете се / пријавете се

A 41-year-old woman presented to her primary doctor with nausea, back pain and lower extremity oedema. Initial labs showed elevated serum creatinine and white blood cell count (WBC), which her doctor attributed to ibuprofen use and a recent upper respiratory infection. Five days later, she presented

Leflunomide-induced toxic epidermal necrolysis in a patient with rheumatoid arthritis.

Само регистрираните корисници можат да преведуваат статии

Пријавете се / пријавете се

BACKGROUND Leflunomide is an immunomodulating agent with proven efficacy in rheumatoid arthritis. Although its overall safety profile is good, a few cases of toxic epidermal necrolysis have been reported. METHODS This 36-year-old woman had rheumatoid arthritis that proved refractory to sulfasalazine

A phase I dose-escalation trial of trastuzumab and alvespimycin hydrochloride (KOS-1022; 17 DMAG) in the treatment of advanced solid tumors.

Само регистрираните корисници можат да преведуваат статии

Пријавете се / пријавете се

OBJECTIVE We conducted a phase I dose-escalation study to define the maximum tolerated dose (MTD), pharmacokinetics (PK), and pharmacodynamics of alvespimycin (17-DMAG), a heat shock protein 90 (Hsp90) inhibitor, given in combination with trastuzumab. METHODS Patients were treated with trastuzumab

Cogan's syndrome: an oculo-audiovestibular disease.

Само регистрираните корисници можат да преведуваат статии

Пријавете се / пријавете се

Typical Cogan's syndrome is a rare disease of young adults consisting of flares of interstitial keratitis and sudden onset of Ménière-like attacks (nausea, vomiting, tinnitus, vertigo and hearing loss). Life-threatening aortic insufficiency develops in 10% of reported cases. Atypical Cogan's

First-in-human trial of an anti-5T4 antibody-monomethylauristatin conjugate, PF-06263507, in patients with advanced solid tumors.

Само регистрираните корисници можат да преведуваат статии

Пријавете се / пријавете се

Background The antibody-drug conjugate PF-06263507 targets the cell-surface, tumor-associated antigen 5T4 and consists of a humanized IgG1 conjugated to the microtubule-disrupting agent monomethylauristatin-F by a non-cleavable maleimidocaproyl linker. In this first-in-human, dose-finding trial

First-in-Human, Multicenter, Phase I Dose-Escalation and Expansion Study of Anti-Mesothelin Antibody-Drug Conjugate Anetumab Ravtansine in Advanced or Metastatic Solid Tumors.

Само регистрираните корисници можат да преведуваат статии

Пријавете се / пријавете се

This phase I study, which to our knowledge is the first-in-human study of this kind, investigates the safety, tolerability, pharmacokinetics, and clinical activity of anetumab ravtansine, an antibody-drug conjugate of anti-mesothelin antibody linked to maytansinoid DM4, in patients

Придружете се на нашата
страница на Facebook

Herbal & Natural Medicine

Најкомплетната база на податоци за лековити билки поддржана од науката

Работи на 55 јазици
Лекови од билки поддржани од науката
Препознавање на билки по слика
Интерактивна GPS мапа - означете ги билките на локацијата (наскоро)
Прочитајте научни публикации поврзани со вашето пребарување
Пребарувајте лековити билки според нивните ефекти
Организирајте ги вашите интереси и останете во тек со истражувањето на новостите, клиничките испитувања и патентите

Напишете симптом или болест и прочитајте за билки што можат да помогнат, напишете билка и видете болести и симптоми против кои се користи.
* Сите информации се базираат на објавени научни истражувања